ASSESSMENT OF CLINICAL AND GENETIC RISK FACTORS OF ARTERIAL HYPERTENSION IN PERSONS YOUNGER THAN 35 YEARS OLD

Aim. To study the specifics of clinical and genetic risk factors, office and 24-hour BP measurements in patients with AH of younger age, who have or have not had an increase of BP in childhood or adolescence.
Material and methods. Totally 54 patients with AH studied at the age of 18-35 y.o. (mean age 25,3±3,4), of those 27 patients had AH since their 18 years age, 27 patients with verified essential AH — since childhood and adolescence. The controls were 26 healthy volunteers (mean age 25,8±3,7). 24-hour monitoring (ABPM) was done with the "ABPM" equipment (Meditech, Hungary). Gene polymorphism was studied using PCR.
Results. In AH patients of child- and adolescent age there was significantly more prevalent abdominal obesity comparing to the group of AH patients not having the anamnesis of BP increase in that age (55,6% and 25,3%, resp., p=0,002). MS in AH patients of child- and adolescent age was two times more prevalent comparing to the group not having BP increase in that age (51,8% and 25,9%, resp., p=0,05). In comparison of RMS genes polymorphism and endothelial NO-syntase in the group of patients not having BP increase during childhood and adolescence, the genotype T/M of AGTgene is more prevalent (51,8% and 20,8%, resp.), and in comparison with control group genotype d/d of gene ACE (29,6% and 8%, resp.) and genotype A/C gene AT1R (48,1% and 20%, resp.)

Conclusion. In patients with AH since childhood and adolescence there is higher prevalence of abdominal obesity and metabolic syndrome, but in patients with AH not having hypertension since this age, genetic factor prevail that probably influence the forming and course of AH in these groups with AH.

1. Shal’nova SA, Balanova JuA, Konstantinov VV, et al. Arterial hypertension: prevalence, awareness, antihypertensive drugs and treatment efficacy in the population of the Russian Federation. Russian Journal of Cardiology 2006; 4: 45-50. Russian (Шальнова С. А., Баланова Ю. А., Константинов В. В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Российский кардиологический журнал 2006; 4: 45-50).

2. Aleksandrov AA, Bubnova MG, Kisljak OA, et al. Guidelines on the cardiovascular diseases prevention in childhood and adolescence. Russian Journal of Cardiology 2012; 6 (98): Suppl. 1. Russian (Александров А. А., Бубнова М. Г., Кисляк О. А. и др. Рекомендации по профилактике сердечно-сосудистых заболеваний в детском и подростковом возрасте. Российский кардиологический журнал 2012; 6 (98): приложение 1.)

3. Bevers G, Lip G, O’Brien E. Arterial hypertension. M.: Publishing house “Binom”; 2005; p. 176. Russian Биверс Г, Лип Г, О’Брайен Э. Артериальная гипертония. М.: Издательство “Бином”, 2005; с.176.

4. Chazova IE, Oshhepkova EV, Zhernakova JuV, et al. Guidelines for the management of patients with metabolic syndrome. Cardiology vestnik 2014; 1: том IX (XXI): 4-57. Russian (Чазова И. Е., Ощепкова Е. В., Жернакова Ю. В. и др. Рекомендации по ведению больных с метаболическим синдромом. Кардиологический вестник 2014; 1: том IX (XXI): 4-57).

5. Chiolero A, Cachat F, et al. Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight. J. of Hypertens 2007; 25: 2209-17.

6. Schmieder R, Hilgers K, Schlaich M, et al. Renin-angiotensin system and cardiovascular risk. Lancet 2007; 7: 369(9568):1208-19.

7. Miyama N, Hasegawa Y, Suzuki M, et al. Investigation of Major Genetic Polymorphisms in the Renin-Angiotensin-Aldosterone System in Subjects with Young-Onset Hypertension Selected by a Targeted-Screening System at University. Clin Exp Hypertension 2007; 29(1): 61-7.

8. Juhola J, Oikonen M, Magnussen CG. Childhood physical, environmental, and genetic predictors of adult hypertension: the cardiovascular risk in young Finns study. Circulation 2012; 126(4): 402-9.

9. Li L, Law C, Power C. Body mass index throughout the life course and blood pressure in mid-adult life: a birth cohort study. J Hypertens 2007; 25: 1215-23.

10. Hulsen HT, Nijdam ME, Bos WJ, et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens. 2006; 24(6): 1027-32.

11. Cheng H, Yan YK, Duan JL, et al. Association between obesity in childhood and

12. hypertension incidence: a prospective cohort study. Zhonghua Yu Fang Yi Xue Za Zhi 2011;

13. (8): 696-701.

14. Shevchenko OV, Svistunov AA, Borodulin VB, et at. Genetic basis of the pathogenesis of

15. essential hypertension. Saratov Journal of Medical Scientific 2011; 7, 1: 83-7. Russian (Шевченко О. В., Свистунов А. А., Бородулин В. Б. и др. Генетические основы патогенеза эссенциальной артериальной гипертензии. Саратовский научно-медицинский журнал 2011; 7, 1: 83-7).

16. Fox CS, Heard-Costa NL, Vasan RS, et al. Genomewide linkage analysis of Weight Change in the Framingham Heart Study. J. Clin. endocrinol. Metab. 2005; 15: 3197-3201.

17. Chandra S, Narang R, Sreenivas V, et al. Association of angiotensin II type 1 receptor (A1166C) gene polymorphism and its increased expression in essential hypertension: a case-control study. PLoS One. 2014;9(7):e101502. doi: 10.1371/journal.pone.0101502. eCollection 2014.

18. Mohana VU, Swapna N, Surender RS, et al. Gender-related association of AGT gene variants (M235T and T174M) with essential hypertension-a case-control study. Clin Exp Hypertens. 2012; 34(1): 38-44.